Member Log-in

I forgot my password

Not a Member? Register

LNCT Welcomes Curatio

CIF logo

The Curatio International Foundation (CIF) has joined the Learning Network for Countries in Transition as a regional partner based in Tbilisi, Georgia. Curatio brings a thorough understanding of the financial and programmatic aspects of immunization programs, expertise in health systems, financing and policy, and extensive experience on transition and sustainability of Gavi supported programs.

Curatio will work together with Results for Development to provide technical facilitation and regional network support, and will significantly contribute to the fruitful and effective functioning of LNCT.

You May Also Like

TVEE Publishes Open Source Health Economics Courses on OpenCourseWare

The Teaching Vaccine Economics Everywhere (TVEE) project is pleased to announce that three modules from its vaccine economics curriculum are now available to the public for free on the JHSPH OpenCourseWare (OCW). The modules published are Health Economics for Vaccines, Costing in Vaccine Planning and Programming, and Economic Evaluation and are available here. Anybody can … Continued

The Equity Impact Vaccines May Have On Averting Deaths And Medical Impoverishment In Developing Countries

A team of researchers modeled the equity impact of lives saved and medical impoverishment averted from immunization over the period 2016-30 in 41 low and middle income countries (DHS survey availability determined which countries were selected for inclusion). Of our 15 LNCT member countries, data from Armenia, Ghana, Indonesia, Nigeria, and Timor-Leste were included in … Continued

New Rotavirus Vaccine Prequalified by WHO

Bharat Biotech announced that ROTAVAC® has achieved pre-qualification by the World Health Organization (WHO), making it available for procurement by United Nations agencies and GAVI, the Vaccine Alliance, for use in low-resource countries. ROTAVAC is substantially cheaper than current rotavirus vaccines on the global market and will be available at $1/dose. Read more about ROTAVAC’s … Continued

Choose a Language